PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
31-Jan-2024 New investigator-initiated clinical trials of BellaSeno´s resorbable tissue regeneration scaffolds to be conducted in Europe BellaSeno GmbH
30-Jan-2024 Huxley Health Inc. Provides Corporate Update - Appoints Bruce Linton as Chairman Huxley Health Inc
30-Jan-2024 ABPI welcomes Labour's life sciences plan ABPI
30-Jan-2024 Fabentech awarded €7.7m from the European Commission as coordinator of the e FabRIC consortium to develop an innovative broad-spectrum therapy against emerging viruses with pandemic potential Fabentech
30-Jan-2024 Axplora invests €8 million in Le Mans to further expand its capacity for antibody drug conjugate manufacturing Axplora
30-Jan-2024 OPEN X Health launches to provide data-driven creativity to the pharmaceutical industry OPEN X Health
30-Jan-2024 HUTCHMED Receives ELUNATE® (fruquintinib) Marketing Approval in Hong Kong for Treatment of Metastatic Colorectal Cancer HUTCHMED
30-Jan-2024 Cresset Aims to Optimise Drug Discovery with Latest Drug Design Platform Release Cresset
30-Jan-2024 RECOMMENDED ALL-SHARE ACQUISITION OF THE ASSETS OF ARIX BIOSCIENCE PLC ("Arix") RTW BIOTECH OPPORTUNITIES LTD ("RTW Bio")
29-Jan-2024 Aripiprazole once-every-two-months long-acting injectable recommended for approval in the EU by the CHMP for the maintenance treatment of schizophrenia in adult patients stabilised with aripiprazole Otsuka Pharmaceutical
29-Jan-2024 Update on Regulatory Review of leriglitazone in the EU Minoryx Therapeutics
29-Jan-2024 LILLY RECEIVES MHRA MARKETING AUTHORISATION IN GREAT BRITAIN FOR TIRZEPATIDE (MOUNJARO ®▼) IN ALTERNATIVE KWIKPEN® PRESENTATION FOR TWO INDICATIONS Lilly
29-Jan-2024 Cherwell launches Redipor® Beta Bags to support continuous manufacturing of sterile medicinal products Cherwell
26-Jan-2024 Cognizant Helping to Modernise Infrastructure and Application Management as Part of Takeda’s Digital Transformation Cognizant 
26-Jan-2024 Biomunex Pharmaceuticals announces the start of a Phase 1 clinical trial for its first-in-class bispecific antibody for the treatment of cancer Biomunex Pharmaceuticals (Biomunex)
26-Jan-2024 Eliminating cervical cancer across the UK could save the economy £2.6 billion, new research finds OHE
26-Jan-2024 LEO Pharma announces positive phase 3 head-to-head data results from DELTA FORCE trial comparing delgocitinib cream with alitretinoin capsules in adults with severe chronic hand eczema (CHE) LEO Pharma
26-Jan-2024 Kyowa Kirin successfully completes acquisition of Orchard Therapeutics, a global gene therapy leader for rare diseases Kyowa Kirin
26-Jan-2024 International life sciences marketing agency announces strategic rebrand ramarketing
26-Jan-2024 Fórsa and the European Biosafety Network call for greater protection for healthcare workers from exposure to hazardous medicinal products Fórsa